Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
threo-7,9,9-Trihydroxy-3,3-dimethoxy-8-O-4-neolignan 4-O-beta-D-glucopyranoside
threo-7,9,9-Trihydroxy-3,3-dimethoxy-8-O-4-neolignan 4-O-beta-D-glucopyranoside
CAS No. 1009838-88-3
threo-7,9,9-Trihydroxy-3,3-dimethoxy-8-O-4-neolignan 4-O-beta-D-glucopyranoside( —— )
Catalog No. M32671 CAS No. 1009838-88-3
The herbs of Leucaena leucocephala.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 461 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Namethreo-7,9,9-Trihydroxy-3,3-dimethoxy-8-O-4-neolignan 4-O-beta-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe herbs of Leucaena leucocephala.
-
DescriptionThe herbs of Leucaena leucocephala.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1009838-88-3
-
Formula Weight540.6
-
Molecular FormulaC26H36O12
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Carboxypeptidase G2 ...
Carboxypeptidase G2 (CPG2) Inhibitor (CPG2 Inhibitor) is a new CPG2 Inhibitor with antitumor activity.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Pirazolac
Pirazolac (ZK-76604) is a novel non-steroidal anti-inflammatory agent for the study of rheumatoid arthritis.
